Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) EBIT Margin: 2010-2016

Historic EBIT Margin for Tenax Therapeutics (TENX) over the last 2 years, with Dec 2016 value amounting to -2,801,940.35%.

  • Tenax Therapeutics' EBIT Margin was N/A to -2,801,940.35% in Q4 2016 from the same period last year, while for Dec 2016 it was -3,418.54%, marking a year-over-year change of. This contributed to the annual value of 84,756.52% for FY2024, which is 5044819.00% up from last year.
  • Per Tenax Therapeutics' latest filing, its EBIT Margin stood at -2,801,940.35% for Q4 2016, which was down 62,937.55% from -4,444.87% recorded in Q2 2013.
  • Over the past 5 years, Tenax Therapeutics' EBIT Margin peaked at -132.62% during Q4 2012, and registered a low of -2,801,940.35% during Q4 2016.
  • Its 1-year average for EBIT Margin is -2,801,940.35%, with a median of -2,801,940.35% in 2016.
  • Over the last 5 years, Tenax Therapeutics' EBIT Margin had its largest YoY gain of 914,614bps in 2012, and its largest YoY loss of 1,162,433bps in 2012.
  • Quarterly analysis of 3 years shows Tenax Therapeutics' EBIT Margin stood at -132.62% in 2012, then crashed by 249,266bps to -4,444.87% in 2013, then reached -2,801,940.35% in 2016.
  • Its EBIT Margin was -2,801,940.35% in Q4 2016, compared to -4,444.87% in Q2 2013 and -715.64% in Q1 2013.